Skip to content
Shuttingdown

bioAffinity Technologies, Inc.

Services-Commercial Physical & Biological Research · SAN ANTONIO

Distress signal

Moderate confidence (50%)

Updated Oct 18, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: bioAffinity Technologies, Inc. received a delisting notice from its exchange (Jul 30, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. bioAffinity Technologies, Inc. received a delisting notice from its exchange

    Jul 30, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 30, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the Company ) received written notice (the Staff Determination ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff has determined that the bid price of the Company s listed securities has closed at less than $1.00 per share over the previous thirty consecutive business days (from June 16, 2026 through July 29, 2026) and, as a result, the Co…”

Company information

Founded
—
Employees (estimate)
—
Industry
Services-Commercial Physical & Biological Research
Subindustry
—
Listing
SEC lists the tickers BIAF and BIAFW on Nasdaq.
SEC CIK
0001712762
Website
—
LinkedIn
—
Headquarters
SAN ANTONIO
Also known as
bioAffinity Technologies, Inc.
Legal entities
bioAffinity Technologies, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    bioAffinity Technologies, Inc. — Services-Commercial Physical & Biological Research (SIC 8731) — SAN ANTONIO, TX
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 30, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the Company ) received written notice (the Staff Determination ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Staff has determined that the bid price of the Company s listed securities has closed at less than $1.00 per share over the previous thirty consecutive business days (from June 16, 2026 through July 29, 2026) and, as a result, the Co…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.